0001209191-19-024239.txt : 20190410
0001209191-19-024239.hdr.sgml : 20190410
20190410162402
ACCESSION NUMBER: 0001209191-19-024239
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190408
FILED AS OF DATE: 20190410
DATE AS OF CHANGE: 20190410
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MERRIWEATHER ALFRED G
CENTRAL INDEX KEY: 0001211839
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36399
FILM NUMBER: 19741912
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adamas Pharmaceuticals Inc
CENTRAL INDEX KEY: 0001328143
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 421560076
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
BUSINESS PHONE: 510-450-3554
MAIL ADDRESS:
STREET 1: 1900 POWELL ST., SUITE 1000
CITY: EMERYVILLE
STATE: CA
ZIP: 94608
FORMER COMPANY:
FORMER CONFORMED NAME: NeuroMolecular Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050524
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-04-08
0
0001328143
Adamas Pharmaceuticals Inc
ADMS
0001211839
MERRIWEATHER ALFRED G
C/O ADAMAS PHARMACEUTICALS, INC.
1900 POWELL ST., SUITE 1000
EMERYVILLE
CA
94608
0
1
0
0
Chief Financial Officer
Common Stock
2019-04-08
4
A
0
25000
0.00
A
49603
D
Stock Option (Right to Buy)
6.81
2019-04-08
4
A
0
50000
0.00
A
2029-04-07
Common Stock
50000
50000
D
The shares of Common Stock are to be acquired upon the vesting of certain Restricted Stock Units granted to the Reporting Person. The Restricted Stock Units shall vest as follows: 25% of the total number of Restricted Stock Units will vest on each of March 20, 2020, March 20, 2021, March 20, 2022 and March 20, 2023, subject to Reporting Person's Continuous Service as of each such date.
The Option shares shall vest as follows: 1/48th of the option shares shall vest on the 1st of each month beginning with May 1, 2019, subject to Reporting Person's Continuous Service as of each such date.
/s/Jennifer Rhodes, as Attorney-in-Fact
2019-04-10